期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 125, 期 3, 页码 1228-1242出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI77656
关键词
-
资金
- Ministry of Science and Technology of China [2012CB945100, 2011CB503906]
- National Natural Science Foundation of China [91439204, 31371154]
- Natural Science Foundation of China (NSFC)/Canadian Institutes of Health Research (CIHR) [NSFC81161120538, CIHR-CCI117951]
- Science and Technology Commission of Shanghai Municipality [14JC1407400, 13ZR1425700]
- One Hundred Talents Program of the Chinese Academy of Sciences [20100HTP10]
- Department of Veterans Affairs [1BX000616]
- Ontario Heart and Stroke Foundation
Pulmonary arterial hypertension (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmonary disease (COPD). Prostacyclin analogs are widely used in the management of PAH patients; however, clinical efficacy and long-term tolerability of some prostacyclin analogs may be compromised by concomitant activation of the E-prostanoid 3 (EP3) receptor. Here, we found that EP3 expression is upregulated in pulmonary arterial smooth muscle cells (PASMCs) and human distal pulmonary arteries (PAs) in response to hypoxia. Either pharmacological inhibition of EP3 or Ep3 deletion attenuated both hypoxia and monocrotaline-induced pulmonary hypertension and restrained extracellular matrix accumulation in PAs in rodent models. In a murine PAH model, Ep3 deletion in SMCs, but not endothelial cells, retarded PA medial thickness. Knockdown of EP3 alpha and EP3 beta, but not EP3 gamma, isoforms diminished hypoxia-induced TGF-beta 1 activation. Expression of either EP3 alpha or EP3 beta in EP3-deficient PASMCs restored TGF-beta 1 activation in response to hypoxia. EP3 alpha/beta activation in PASMCs increased RhoA-dependent membrane type1 extracellular matrix metalloproteinase (MMP) translocation to the cell surface, subsequently activating pro-MMP-2 and promoting TGF-beta 1 signaling. Activation or disruption of EP3 did not influence PASMC proliferation. Together, our results indicate that EP3 activation facilitates hypoxia-induced vascular remodeling and pulmonary hypertension in mice and suggest EP3 inhibition as a potential therapeutic strategy for pulmonary hypertension.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据